Oxo-azabicyclic compounds
AssigneeWarner-Lambert Company
InventorsBernard Gaudilliere, Henry Jacobelli, Catherine Kostlan, Jack Jie Li, Wen-Song Yue
Life of this patent
Estimating the term…
Loading patent…
AssigneeWarner-Lambert Company
InventorsBernard Gaudilliere, Henry Jacobelli, Catherine Kostlan, Jack Jie Li, Wen-Song Yue
Estimating the term…
A compound selected from those of formula (I): 1 wherein: X1, X2, and X3, represent N or —CR3 in which R3 is as described in the description, G1 represents a group selected from those of formulae (i/a) and (i/b): 2 in which R4, R5, and R6 are as defined in the description, G2 represents a group selected from carbon-carbon triple bond, —CH═C═CH—, C═O, C═S, S(O)n1 in which n1 represents an integer from 0 to 2 inclusive, or a group of formula (i/c): 3 in which Y1 represents O, S, —NH or —Nalkyl, and Y2 represents O, S, —NH or —Nalkyl, n is an integer from 0 to 6 inclusive, and m is an integer from 0 to 7 inclusive, Z1 represents —CR9R10, wherein R9 and R10 are as defined in the description, A represents a ring system, R1 represents a group selected from H, alkyl, alkenyl, alkynyl, optionally substituted and the group of formula (i/d): 4 in which p, Z2, B, q and G3 are as defined in the description and optionally, its optical isomers, N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of type-13 matrix mettaloprotease.
1- A compound selected from those of formula (I):
2- A compound according to claim 1 wherein:
3- A compound according to claim 1 wherein:
4- A compound according to claim 1, which is selected from:
5- A compound according to claim 1, which is selected from:
6- A compound according to claim 1, which is selected from:
7- A pharmaceutical composition, comprising as active ingredient an effective amount of a compound as claimed in claim 1, in combination with a pharmaceutically-acceptable excipient or carrier.
8- A method for treating a living body afflicted with a disease selected from arthritis, rheumatoid arthritis, osteoarthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, cardiac insufficiency, atherosclerosis, asthma, chronic obstructive pulmonary disease, age-related macular degeneration, and cancers, comprising the step of administering to the living body an amount of a compound of claim 1 which is effective for alleviation of said disease.
9- The method according to claim 8,wherein the disease is arthritis.
10- The method according to claim 8,wherein the disease is osteoarthritis.
11- The method according to claim 8,wherein the disease is rheumatoid arthritis.